When someone is told they have hardened or blocked arteries, they’re usually prescribed drugs or surgery that minimize the symptoms. They’re also told that it will slowly get worse, and while diet and exercise can slow it, no treatment will stop or reverse the process. But that’s about to change.

Hundreds of studies show that root causes of heart disease aren’t being treated by standard prescription drugs and surgery. This partially explains why heart disease remains the leading cause of death. The lack of treatment for causes is no surprise to cardiologists, who know how most of those are aimed at symptoms or secondary triggers.

The problem is that researchers haven’t been able to target one of the primary causes – oxidative stress degrading the elastic that keeps  arteries flexible. This degradation triggers chronic inflammation leading to hardening and clogging of blood vessels. The whole process turns our body’s normally protective repair processes against us.

Today’s treatments focus on risk factors like cholesterol, hypertension, age, obesity, and smoking. Those are based on studies known as the Framingham studies conducted over the past 40 years. The studies aren’t themselves wrong – especially when it comes to smoking and obesity – but beneath those risk factors are other stresses that drive degrading of arteries.

Here are seven types of stress that standard therapies aren’t designed to treat, but that some researchers are beginning to learn how to target.

  1. Toxic metals and other pollutants that degrade the elastic in arteries. These are in the air, water and soil, and some have been with us for thousands of years.
  2. Low level infections that escape detection and trigger constant inflammation. These include common infections like gingivitis and the bacteria that causes ulcers. Other more recent infections such as COVID-19 contribute.
  3. Chronic noise from traffic and other sources.
  4. Emotional stress.  Standard therapies also don’t target the direct impacts of those stresses, including:
  5. Oxidative stress degrading the elastic fiber in our arteries. After we pass the age of 30, our body doesn’t assemble this fiber anymore, so it continues to degrade, triggering a vicious cycle.
  6. Our immune system turning against us when it tries to fix the damage. This leads to chronic inflammation and the typical plaque that we do often hear about.
  7. That inflammation also leads to hardening the arteries when the body tries to wall off the damage. The calcified crystals that form this rock-hard material are themselves a type of stress because they trigger further inflammation. The end product is often hypertension.

“The standard prescribed therapies for cardiovascular disease and other chronic illnesses have not succeeded in resolving this problem because they’re not targeted towards it,” explains Dr. Gervasio Lamas, Chief of Cardiology, Mt. Sinai Medical Center & Columbia University.


“The standard prescribed therapies for cardiovascular disease and other chronic illnesses have not succeeded in resolving this problem because they’re not targeted towards it.”


The Good News​

Clinical evidence gathered by Lamas and others over many years shows that a few innovative therapies can remove toxic metals, restore the elastic in arteries, and reduce chronic inflammation. These therapies range from nutraceutical combinations to new nanotechnologies and infusions of metal-removing chemicals. For example:

  • A naturally derived chemical known as a polyphenol was discovered by scientists at Clemson University in South Carolina to kick-start the elastin assembly process. Pre-clinical results demonstrate that often deadly aneurysms can be reversed when the bulges in arteries are resolved. The therapy is entering clinical trial and results should be available in 18 months. Check clinicaltrials.gov and look for keyword Nectero.
  • A ten-year NIH-funded clinical trial that infused metal-removing agents and vitamins into arteries of patients resulted in a 42% reduction in all causes of death for diabetic heart patients. That same therapy prevented amputations in diabetic patients with Peripheral Artery Disease who has lost the circulation in their feet. A second national trial is underway supervised by doctors at Mt. Sinai Medical Centre. Results will be known by the end of 2023. Check TACT2.org for updates.
  • A non-prescription nutraceutical known as NanobacTX developed 20 years ago has shown consistent success in improving heart health by attacking hidden infections and inflammation, and is recommended by leading cardiologists. Check nanobiotechpharma.com for more.

If these work, why haven’t most people heard of them?  Certainly it’s not the fault of doctors – they see the impacts every day, but their hands are often tied by the health care and insurance systems that they have to work with. Lethargic systems and old school thinking are holding back doctors and their patients.

But things are changing as patients take charge of their own health. The stories of how they’re doing it have been assembled by a seasoned author who spent decades researching them while co-founding a medical biotech company and developing healthy products. That special combination of insights allowed Douglas Mulhall to see how targeting hidden stress is opening new doors to healthier longevity.

The book, Discovering the Nature of Longevity: Restoring the heart and body by targeting hidden stress, comes recommended by the American Institute of Stress in its official podcast, and includes a Foreword by Dr. Gervasio Lamas, one of America’s leading clinical trial cardiologists. The book debuted in April 2023 at #1 in seven Amazon book categories.

“While doing the research for this book I was astounded by how much valuable therapy is out there that patients and their doctors simply aren’t hearing about,” says Mulhall, “The system has not caught up with the science, and I wrote the book to accelerate that catch-up.”


For more information. Listen to the podcasts on FuturesNetwork.TV and check out the book at https://a.co/d/h5kikh2 .